Bridgeway Capital Management, LLC Bio Atla, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 115,000 shares of BCAB stock, worth $54,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115,000
Previous 90,000
27.78%
Holding current value
$54,050
Previous $123,000
64.23%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BCAB
# of Institutions
65Shares Held
17.4MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.25 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.18 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$886,0680.0% of portfolio
-
Morgan Stanley New York, NY1.86MShares$873,3420.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$410,8150.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $17.1M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...